Ken Fisher Emergent Bio Solutions Inc. Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$20.09 - $35.8 $837,933 - $1.49 Million	-41,709 Reduced 7.7%	500,080 $10.5 Million
Q2 2022 Aug 09, 2022	BUY	$27.42 - $43.63 $1.54 Million - $2.44 Million	56,002 Added 11.53%	541,789 $16.8 Million
Q1 2022 May 05, 2022	SELL	$36.48 - $52.22 $454,467 - $650,556	-12,458 Reduced 2.5%	485,787 $19.9 Million
Q4 2021 Feb 02, 2022	SELL	$33.11 - $55.01 $1.01 Million - $1.68 Million	-30,591 Reduced 5.78%	498,245 $21.7 Million
Q3 2021 Oct 26, 2021	BUY	$50.07 - $66.05 $1.67 Million - $2.21 Million	33,419 Added 6.75%	528,836 $26.5 Million
Q2 2021 Jul 27, 2021	BUY	$56.61 - $80.46 $774,707 - $1.1 Million	13,685 Added 2.84%	495,417 $31.2 Million
Q1 2021 Apr 27, 2021	SELL	$86.23 - $125.19 $312,497 - $453,688	-3,624 Reduced 0.75%	481,732 $44.8 Million
Q4 2020 Jan 29, 2021	SELL	$79.17 - $111.47 $1.37 Million - $1.93 Million	-17,342 Reduced 3.45%	485,356 $43.5 Million
Q3 2020 Nov 10, 2020	SELL	$81.91 - $134.94 $4.7 Million - $7.74 Million	-57,325 Reduced 10.24%	502,698 $51.9 Million
Q2 2020 Aug 07, 2020	SELL	$54.33 - $89.52 $1.41 Million - $2.32 Million	-25,935 Reduced 4.43%	560,023 $44.3 Million
Q1 2020 Apr 28, 2020	SELL	$49.34 - $68.76 $2.22 Million - $3.1 Million	-45,026 Reduced 7.14%	585,958 $33.9 Million
Q4 2019 Feb 12, 2020	SELL	$51.21 - $59.06 $1.57 Million - $1.81 Million	-30,587 Reduced 4.62%	630,984 $34 Million
Q3 2019 Oct 29, 2019	BUY	$40.6 - $57.2 $146,728 - $206,720	3,614 Added 0.55%	661,571 $34.6 Million
Q2 2019 Jul 30, 2019	BUY	$39.92 - $53.86 $4.97 Million - $6.7 Million	124,413 Added 23.32%	657,957 $31.8 Million
Q1 2019 Apr 22, 2019	BUY	$48.23 - $66.16 $1.51 Million - $2.07 Million	31,363 Added 6.25%	533,544 $27 Million
Q4 2018 Jan 25, 2019	BUY	$55.63 - $73.24 $11.2 Million - $14.8 Million	201,706 Added 67.13%	502,181 $29.8 Million
Q3 2018 Oct 24, 2018	SELL	$52.05 - $66.51 $2.66 Million - $3.4 Million	-51,100 Reduced 14.53%	300,475 $19.8 Million
Q2 2018 Jul 09, 2018	SELL	$48.33 - $55.64 $1.27 Million - $1.46 Million	-26,288 Reduced 6.96%	351,575 $17.8 Million
Q1 2018 May 11, 2018	SELL	$44.44 - $54.39 $22.7 Million - $27.8 Million	-510,948 Reduced 57.49%	377,863 $19.9 Million
Q1 2018 Apr 19, 2018	BUY	$44.44 - $54.39 $20.4 Million - $25 Million	459,243 Added 106.91%	888,811 $46.8 Million
Q4 2017 Jan 24, 2018	SELL	$37.77 - $47.75 $117,540 - $148,598	-3,112 Reduced 0.72%	429,568 $20 Million
Q3 2017 Oct 17, 2017	BUY	$34.14 - $40.45 $14.8 Million - $17.5 Million	432,680	432,680 $17.5 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account